Oxytocin Research Guide — OXTR/Gq/PLC–β/Ca²♠ Signaling, Social Behavior, Uterine Biology & Neuroimmune Modulation (2026)
- Oxytocin (OXT) is a 9-amino acid cyclic neuropeptide (sequence: Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH&sub2;; MW ~1,007 Da; disulfide bond between Cys1 and Cys6; C-terminal amidation) synthesized primarily in paraventricular nucleus (PVN) and supraoptic nucleus (SON) neurons of the hypothalamus and released by the neurohypophysis (posterior pituitary). One of the most extensively studied neuropeptides: >25,000 PubMed publications since 1930 spanning reproductive, social, neuroimmune, and metabolic biology. YPB offers research-grade oxytocin (Research Use Only).
- Mechanism: Oxytocin binds the OXTR (oxytocin receptor) — a single-subtype Class A GPCR expressed in uterus, mammary gland, brain (amygdala, prefrontal cortex, hippocampus, hypothalamus, VTA), heart, kidney, bone, and immune cells. OXTR couples primarily to Gq/G11 → PLC-β activation → IP3 + DAG production. IP3 triggers Ca²+ release from ER stores → elevated cytosolic Ca²+ → MLCK activation (smooth muscle contraction; uterine/myometrial) or neurotransmitter release modulation (CNS). DAG activates PKC → downstream MAPK/ERK1/2 signaling. OXTR also couples to Gi/Go in some tissues (reducing cAMP) and to Gs in others. Recent discovery (2024): TRPV4 calcium channel colocalizes with OXTR in myometrial cells and is required for oxytocin-induced Ca²+ influx and uterine contractility.
- Primary research applications: (1) uterine contraction/myometrial biology (labor mechanism; tocolytic target research; postpartum hemorrhage); (2) social behavior and neuromodulation (pair bonding, trust, maternal behavior, autism spectrum disorder models, anxiety, HPA axis dampening); (3) neuroimmune modulation (anti-inflammatory effects, autonomic nervous system); (4) bone biology (osteoblast/osteoclast regulation); (5) metabolic research (appetite, glycemic control in animal models).
- FDA context: Synthetic oxytocin (Pitocin; Syntocinon) is research-grade for labor induction and postpartum hemorrhage. Research-grade oxytocin is not equivalent to compound preparations. Not for research use only. Research Use Only (RUO). Updated April 2026.
What Is Oxytocin and Why Does It Span So Many Research Domains?
25,000+ PubMed Publications
OXTR Gq/PLC-β/Ca²+ Signaling
Oxytocin was first isolated in 1906 by Henry Dale, who documented its uterotonic properties, and its structure was determined by Vincent du Vigneaud in 1953 — the work for which he received the 1955 Nobel Prize in Chemistry. Updated April 2026. For much of the 20th century, oxytocin was studied primarily as a reproductive hormone (uterine contraction, milk letdown). The past three decades revealed a far broader biological profile: oxytocin is simultaneously a peripheral hormone (released into systemic circulation from neurohypophysis) and a central neurotransmitter/neuromodulator (released locally from axon terminals and dendrites in multiple brain regions). This dual peripheral/central release pattern, combined with OXTR expression across a remarkably wide range of tissues, explains why oxytocin research spans everything from myometrial contraction mechanics to social behavior neuroscience to bone metabolism to immune function.
Key Characteristics
| Parameter | Value |
|---|---|
| Sequence | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH&sub2; (9 AA; cyclic via Cys1–Cys6 disulfide bond; C-terminal amidation) |
| Molecular Weight | ~1,007 Da |
| Discovery | Dale (1906; uterotonic activity); du Vigneaud et al. (1953; structure determination); first synthetic peptide to be sequenced and synthesized — Nobel Prize Chemistry 1955 |
| Synthesis Sites | Paraventricular nucleus (PVN) and supraoptic nucleus (SON) of hypothalamus; also produced in peripheral tissues (uterus, heart, thymus, placenta) |
| Receptor (OXTR) | Single subtype; Class A Gs/Gq/Gi-coupled GPCR; expressed in uterus, mammary gland, brain (amygdala, PFC, hippocampus, hypothalamus, VTA, nucleus accumbens), heart, kidney, bone, immune cells |
| Primary Signal Cascade | OXTR → Gq/G11 → PLC-β → IP3 + DAG; IP3 → ER Ca²+ release → cytosolic Ca²+ ↑; DAG → PKC → MAPK/ERK1/2; also Gi/Go (reduces cAMP in some tissues) |
| Uterine Contraction Mechanism | OXTR/Gq/PLC-β/IP3 → Ca²+ release + TRPV4 channel-mediated Ca²+ influx → MLCK (myosin light chain kinase) activation → smooth muscle contraction; also prostaglandin production (PGE2, PGF2α) via arachidonic acid → amplifies contraction |
| CNS Social Behavior | Amygdala: modulates social salience processing; reduces fear/anxiety; PFC: trust, social decision-making; hippocampus: social memory; VTA/NAc: reward circuits, pair bonding; HPA axis: oxytocin suppresses CRH → reduces cortisol |
| Half-Life | ~3–5 min plasma (rapidly degraded by oxytocinase/leucyl-cystinyl aminopeptidase; oxytocin-degrading aminopeptidase); intranasal delivery bypasses systemic degradation for CNS research protocols |
| FDA Status | Synthetic oxytocin (Pitocin; Syntocinon) research-grade for labor induction and postpartum hemorrhage. Research-grade oxytocin is not equivalent. Research Use Only (RUO). |
| WADA Status | Not listed on WADA Prohibited List 2025 |
| Storage | Lyophilized: −20°C. Reconstituted in sterile PBS or acetic acid/water; 2–8°C, use within 14 days. Sensitive to oxidation of Cys disulfide bond; avoid oxidizing conditions. |
How Does Oxytocin Signal? OXTR/Gq/PLC-β/Ca²+ Cascade
OXTR Structure and G Protein Coupling
The OXTR is a seven-transmembrane Class A GPCR with a single gene-encoded subtype (unlike the two-subtype VPAC1/VPAC2 system of VIP). Despite being a single receptor subtype, OXTR can couple to multiple G proteins depending on cell type and expression context: primary coupling is Gq/G11 (mediates most peripheral and CNS effects); secondary coupling to Gi/Go occurs in some tissues (inhibits adenylyl cyclase, reduces cAMP, may mediate some anti-inflammatory effects); and Gs coupling has been documented in specific contexts. This G protein promiscuity accounts for the diverse downstream effects of OXTR activation across different tissues. OXTR expression is also dynamically regulated: uterine OXTR expression increases enormously at the end of pregnancy (estrogen-dependent upregulation), explaining why oxytocin’s uterotonic effect dramatically amplifies at term.
Gq/PLC-β/IP3/Ca²+: The Contractility Cascade
The primary OXTR/Gq downstream cascade drives calcium mobilization: Gq activates phospholipase C-beta (PLC-β), which cleaves phosphatidylinositol-4,5-bisphosphate (PIP2) into inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 binds IP3 receptors on the endoplasmic reticulum membrane, triggering Ca²+ release into the cytoplasm. This cytosolic Ca²+ elevation activates calmodulin-dependent myosin light chain kinase (MLCK) in smooth muscle cells, phosphorylating the myosin regulatory light chain and initiating actomyosin cross-bridge cycling — the molecular basis of smooth muscle contraction. In 2024, a significant mechanistic advance was published: TRPV4 (transient receptor potential vanilloid 4), a Ca²+-permeable ion channel, colocalizes with OXTR at the plasma membrane of myometrial smooth muscle cells, and TRPV4-mediated Ca²+ influx is required for sustained oxytocin-induced contraction. TRPV4 antagonism abolishes oxytocin-induced contractility even when IP3-mediated ER Ca²+ release is intact.
What Research Applications Has Oxytocin Been Studied For?
Uterine Contraction and Reproductive Biology
The foundational oxytocin research application is uterine smooth muscle (myometrial) contraction biology. Synthetic oxytocin (Pitocin) is research-grade for labor induction, reflecting well-validated clinical translational evidence. Research uses: the OXTR/Gq/PLC-β/IP3/Ca²+/MLCK contractility cascade provides a complete in vitro model for studying smooth muscle pharmacology; the role of prostaglandins (PGE2, PGF2α) as secondary oxytocin-driven contractility amplifiers; the TRPV4-OXTR colocalization mechanism (2024 discovery; TRPV4 antagonism as potential tocolytic target for preterm labor research); OXTR upregulation mechanisms during gestation (estrogen-dependent); and postpartum hemorrhage pathophysiology (oxytocin-resistant uterine atony).
Social Behavior Neuroscience
Oxytocin is studied as the primary pharmacological probe for the neuroscience of social behavior. OXTR expressed in the amygdala, prefrontal cortex, hippocampus, and ventral tegmental area/nucleus accumbens reward circuits mediates: pair bonding in prairie voles (the canonical animal model for oxytocin’s pair bonding role); maternal behavior induction; social memory and recognition; trust in economic game paradigms (human intranasal oxytocin studies); anxiety reduction; and social salience processing. Autism spectrum disorder (ASD) research: OXTR genetic variants and hypomethylation have been associated with ASD; intranasal oxytocin has been tested in ASD clinical trials for social behavior improvement (results have been mixed; large heterogeneous literature).
HPA Axis and Stress Response Research
Oxytocin dampens the HPA (hypothalamic-pituitary-adrenal) stress axis: oxytocin released from PVN neurons (same neurons that also produce CRH) inhibits CRH release, suppresses ACTH secretion, and reduces cortisol responses to stressors. This HPA-dampening effect of oxytocin provides a mechanistic link between social bonding (which activates the oxytocin system) and reduced stress reactivity. In research models, oxytocin is used to study the neuroendocrine mechanisms by which social support and affiliative behaviors modulate stress physiology.
Bone Biology Research
OXTR is expressed on osteoblasts and osteoclasts. OXT stimulates osteoblast differentiation (via MAPK1/3) and influences osteoclastogenesis. Published data from Tamma et al. suggest OXT may have a role as a potential modulator in osteoporosis research. This is a newer and less extensively validated application than uterine or behavioral biology, but represents an active emerging research area.
What Does the Research Data Show?
| Research Area | Model | Key Finding & Notes | Year(s) |
|---|---|---|---|
| Uterine contraction — TRPV4 discovery | Human myometrial smooth muscle cells; gravid uterus ex vivo | TRPV4 colocalizes with OXTR at plasma membrane; TRPV4 antagonism or siRNA knockdown abolishes oxytocin-induced Ca²+ influx and contractility; TRPV4-OXTR colocalization reduced in oxytocin-resistant uterine atony research subjects. Identifies TRPV4 as critical mediator; potential tocolytic target. (2024; PMID: 41762213) | 2024 |
| Social behavior — Prairie vole pair bonding | Animal model (prairie voles; OXTR knockout) | OXTR in nucleus accumbens required for pair bond formation; oxytocin infusion accelerates bond formation; OXTR antagonist blocks it. Foundational model for oxytocin’s role in pair bonding; widely extrapolated to human social bonding research. Normal cell viability; no toxicity reported at research doses. | Multiple |
| ASD/social behavior — human intranasal trials | Clinical (various; intranasal oxytocin × ASD subjects) | Mixed results across trials; some studies show improved social behavior, eye contact, emotion recognition in ASD; large RUBI-RCT and other Phase 2 trials showed non-significant primary endpoints. Context-dependence of oxytocin effects and dose/route optimization remain active research questions. Well tolerated at research doses. | Multiple |
| HPA axis dampening | Animal and human studies | Oxytocin infusion reduces cortisol responses to social stressors; PVN oxytocin neurons inhibit CRH; OXTR variants (rs53576 GG) associated with lower stress reactivity and greater social support seeking. Mechanistic link between social bonding and HPA axis modulation confirmed in both rodent and human models. Normal physiological effects at research doses. | Multiple |
How Does Oxytocin Compare to Other Neuropeptide Research Compounds?
| Parameter | Oxytocin | VIP | Selank | Kisspeptin |
|---|---|---|---|---|
| Receptor | OXTR (single subtype; Gq/G11 primary; also Gi/Go, Gs); broadly expressed brain + periphery | VPAC1 + VPAC2 (Gs-coupled); immune cells + smooth muscle + SCN | Tuftsin analog; Kiss1R-independent; GABAergic/serotonergic modulation | Kiss1R (GPR54; Gq-coupled); GnRH neurons in hypothalamus; HPG axis |
| Primary Brain Regions | Amygdala, PFC, hippocampus, VTA, nucleus accumbens, PVN, SON | SCN (circadian), cerebral cortex, hippocampus | Primarily CNS anxiolytic; limbic system; GABA | Hypothalamus (GnRH neurons); arcuate nucleus; AVPV |
| Peripheral Actions | Uterine contraction; lactation (milk letdown); cardioprotection; bone; immune; metabolism | Vascular smooth muscle (vasodilation); bronchodilation; GI motility | Primarily CNS; immune-brain axis | Primarily HPG axis; minimal peripheral effects outside reproductive tract |
| Research Breadth | Extremely broad: reproductive biology, social neuroscience, neuroimmune, HPA axis, bone, metabolic | Broad: neuroimmune, vascular, circadian, GI | Focused: anxiety, cognitive, immune-brain axis | Focused: HPG axis, puberty, fertility |
| Half-Life | ~3–5 min (plasma); intranasal route bypasses peripheral degradation for CNS research | <1 min (plasma) | Moderate (tripeptide amide analog) | Short; pulsatile endogenous secretion |
| YPB Position | YPB catalog (RUO) | VIP10 — see guide | YPB.214 — see guide | YPB.276 — see guide |
Oxytocin is the most broadly expressed neuropeptide in the YPB catalog with simultaneous reproductive, social behavioral, and neuroimmune research applications. VIP (see the VIP Research Guide) is the closest mechanistic overlap (both neuropeptides; both peripheral + CNS; both anti-inflammatory) but via completely non-overlapping receptors (OXTR vs. VPAC1/2) and different primary tissues. Selank (see the Selank Research Guide) shares the anxiolytic CNS research angle but via tuftsin/GABAergic mechanisms. Together oxytocin, VIP, and Selank cover three non-overlapping neuropeptide-mediated neurobiological research axes: OXTR social/reproductive/stress, VPAC1/2 neuroimmune/circadian, and tuftsin/GABA anxiolytic.
What Should Researchers Know About Oxytocin Stability and Handling?
Disulfide Bond and Oxidation Sensitivity
Oxytocin’s biological activity depends critically on the intact Cys1–Cys6 disulfide bond that forms the cyclic hexapeptide ring. This ring structure is required for OXTR binding. Oxidative conditions (high O2, metal ions, peroxides) can disrupt the disulfide bond, reducing or eliminating biological activity. COA HPLC analysis should show a single peak; a broad or split peak may indicate disulfide-scrambled or oxidized forms. Reconstitute in degassed sterile water or 0.1% acetic acid (slightly acidic pH of ~4 preserves the disulfide bond during storage); avoid alkaline pH. Prepare aliquots under nitrogen or argon if possible for long-term use. All YPB oxytocin batches include lot-traceable COA documentation through the COA Library.
Route of Administration in Research
Oxytocin’s ~3–5 minute plasma half-life (due to oxytocinase/leucyl-cystinyl aminopeptidase in plasma) limits systemic delivery for CNS research. Intranasal administration has become the standard in human and animal CNS oxytocin research because it bypasses systemic peptidase degradation and achieves CNS delivery via olfactory epithelium trigeminal nerve pathways and perivascular routes. For in vitro research, direct addition to cell culture medium is straightforward; for in vivo CNS research, icv (intracerebroventricular) or intra-amygdala microinjection provides anatomically specific delivery. Research protocols should specify route because dose-response relationships differ dramatically across routes.
Key Research Findings
- Nobel Prize neuropeptide: First synthetic peptide sequenced and synthesized (du Vigneaud 1953; Nobel 1955); >25,000 PubMed publications; one of the most extensively studied signaling molecules in biology.
- OXTR Gq/G11 → PLC-β → IP3 → Ca²+: Primary contractility cascade; IP3 triggers ER Ca²+ release → MLCK activation → smooth muscle contraction; also DAG → PKC → MAPK/ERK1/2.
- TRPV4 colocalization (2024, PMID: 41762213): TRPV4 channel required for oxytocin-induced Ca²+ influx and uterine contractility; TRPV4 antagonism abolishes contraction; reduced in oxytocin-resistant atony. New mechanistic insight with tocolytic research implications.
- OXTR upregulated at term: Estrogen-dependent dramatic OXTR upregulation in myometrium at end of pregnancy; explains why oxytocin becomes maximally uterotonic at delivery.
- Social behavior: amygdala + nucleus accumbens: OXTR in CeA reduces anxiety; OXTR in NAc mediates pair bonding reward; prairie vole model = foundational; human intranasal OXT modulates trust and social salience.
- HPA axis dampening: PVN oxytocin neurons inhibit CRH release; reduces cortisol response to social stress; rs53576 OXTR variant associated with differential stress reactivity.
- ~3–5 min plasma half-life: Oxytocinase degradation; intranasal route bypasses for CNS research; specify route in protocols.
- Disulfide bond required: Cys1–Cys6 ring structure essential for OXTR binding; confirm by HPLC single peak; store in slightly acidic conditions; avoid oxidizing agents.
Browse the Full Research Catalog
Market Demand and Research Interest
| Demand Indicator | Oxytocin Data Point |
|---|---|
| PubMed publications | >25,000 (since 1930); one of the most-studied neuropeptides in biology |
| Clinical context | research-grade Pitocin/Syntocinon for labor induction; active ASD clinical trials; HPA axis modulation research; pain management trials; bone biology emerging |
| Unique catalog position | Only OXTR agonist in YPB catalog; covers reproductive biology (uterine), social neuroscience (amygdala/NAc), HPA axis (PVN), and bone biology from a single neuropeptide |
| Research communities | Reproductive endocrinology (labor/PPH); social neuroscience; ASD research; stress biology/HPA axis; neuroimmunology; bone biology |
| ASD trial context | Multiple published intranasal oxytocin ASD trials; mixed results creating ongoing research interest in optimizing dose, route, timing, and population for behavioral outcomes |
| Keyword difficulty range | Medium-high (KD 30–50); well-known compound; broad public awareness drives search volume |
How Can Researchers Offer Oxytocin Under Their Own Brand?
Wholesale Pricing & Margin Analysis
| SKU | Compound | Premier ($497/mo) | Core ($297/mo) | Suggested MSRP | Premier Margin |
|---|---|---|---|---|---|
| YPB Catalog (RUO) | Oxytocin (9-AA cyclic neuropeptide) | TBC Premier | TBC Core | TBC | TBC at Premier tier |
Contact the YPB team for confirmed SKU, configuration, Premier and Core tier pricing. Use the YPB Profit Calculator to model projected revenue. Oxytocin is one of the highest-recognition research peptides in the catalog — broad public awareness (the “love hormone” popular science narrative) drives catalog visibility for white-label brands targeting the social neuroscience and reproductive biology research markets. Combined with VIP and Selank in a catalog, oxytocin provides OXTR social/reproductive coverage alongside VPAC1/2 neuroimmune and tuftsin/GABAergic anxiolytic — three non-overlapping neuropeptide mechanisms from a single neuroimmune/behavioral research buyer audience. Download the full catalog for all neuropeptide category pricing.
Methodology & Data Sources
Methodology & Data Sources
Scientific literature: PubMed searched for “oxytocin,” “OXTR mechanism,” “oxytocin uterine contraction,” and “oxytocin social behavior.” Search conducted through April 2026.
Key sources: Jurek & Neumann (2018) Physiol Rev (comprehensive OXTR signaling review); PMC10796195 (multifaceted OXTR/social behavior review 2024); PMC5143325 (OXT-OXTR signaling network overview); Ansari et al. (2024, PMID: 41762213, TRPV4-OXTR discovery); PMC9966686 (OXTR roles in disease 2023); du Vigneaud et al. (1953, Nobel Prize structure determination).
Limitations: Oxytocin’s effects are highly context-dependent (route, dose, sex, species, individual OXTR genotype, behavioral context). Published research contains many conflicting findings, particularly in human intranasal studies, that reflect this context-dependence rather than experimental error. The 25,000+ publication literature is heterogeneous in quality; researchers should weight mechanistic studies with receptor-specific tools over correlational or pharmacological approaches. Research-grade oxytocin is not equivalent to compound Pitocin/Syntocinon. This article is for educational purposes only.
References
- Jurek, B., & Neumann, I. D. (2018). The oxytocin receptor: from intracellular signaling to behavior. Physiol Rev, 98(3), 1805–1908. (Comprehensive OXTR signaling review.)
- Ansari, J. R., Fornes, D., Obiyo, L. T., Michel, G., & Cornfield, D. N. (2024). In the gravid human uterus, oxytocin induces smooth muscle cell contraction via transient receptor potential vanilloid 4 channel activation. J Physiol. PMID: 41762213 (TRPV4-OXTR discovery.)
- du Vigneaud, V., Ressler, C., Swan, J. M., Roberts, C. W., Katsoyannis, P. G., & Gordon, S. (1953). The synthesis of an octapeptide amide with the hormonal activity of oxytocin. J Am Chem Soc, 75(19), 4879–4880. (Nobel Prize structure determination.)
- PMC10796195. (2024). The multifaceted role of the oxytocinergic system and OXTR gene.
- PMC5143325. (2017). An overview of the oxytocin-oxytocin receptor signaling network. (Gq/G11/Gi/Go coupling; uterine PG cascade.)
- PMC9966686. (2023). Roles of the oxytocin receptor (OXTR) in human diseases.
- Tamma, R., Colaianni, G., Zhu, L. L., DiBenedetto, A., Greco, G., Montemurro, G., Patano, N., Strippoli, M., Vergari, R., Mancini, L., Mori, G., Colucci, S., Grano, M., Faccio, R., Liu, X., Li, J., Uversky, V., & Zallone, A. (2009). Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci USA, 106(17), 7149–7154. (Bone biology OXT context.)
- Young, L. J., & Wang, Z. (2004). The neurobiology of pair bonding. Nat Neurosci, 7(10), 1048–1054. (Prairie vole OXTR pair bonding foundational review.)
- Carter, C. S. (2014). Oxytocin pathways and the evolution of human behavior. Annu Rev Psychol, 65, 17–39. (HPA axis dampening and social bonding context.)
Frequently Asked Questions
Oxytocin (OXT; Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH&sub2;; MW ~1,007 Da; cyclic disulfide Cys1–Cys6; C-terminal amidated) is a 9-amino acid cyclic neuropeptide synthesized in hypothalamic PVN and SON neurons. In research models, it activates OXTR (Class A GPCR; single subtype) primarily via Gq/G11 → PLC-β → IP3 + DAG → Ca²+ release from ER → MLCK-mediated smooth muscle contraction (uterine/myometrial); also DAG → PKC → MAPK/ERK1/2; also Gi/Go in some tissues. 2024 discovery: TRPV4 channel colocalizes with OXTR in myometrial cells and is required for oxytocin-induced Ca²+ influx and contractility (PMID: 41762213). CNS: OXTR in amygdala, PFC, hippocampus, VTA, NAc mediates social behavior modulation, pair bonding, anxiety reduction, trust, maternal behavior. HPA axis: PVN oxytocin inhibits CRH → reduced cortisol stress response. Also: bone biology, neuroimmune modulation, metabolic signaling. ~3–5 min plasma half-life (oxytocinase). research-grade Pitocin/Syntocinon for labor (not equivalent to research grade). WADA Not Listed. Research Use Only (RUO). Updated April 2026.
TRPV4 (transient receptor potential vanilloid 4) is a Ca²+-permeable non-selective cation channel expressed at the plasma membrane of myometrial smooth muscle cells. A 2024 study (Ansari et al., PMID: 41762213) demonstrated that TRPV4 physically colocalizes with OXTR at the plasma membrane at concentrations below 40 nM and functionally cooperates with OXTR during oxytocin-induced contraction. When TRPV4 is blocked by pharmacological antagonists or genetically knocked down by siRNA, oxytocin-induced Ca²+ influx and uterine contractility are abolished — even though IP3-mediated ER Ca²+ release can still occur. This establishes TRPV4 as a required co-mediator of the full contractility response, not merely a secondary downstream effector. In research subjects with oxytocin-resistant uterine atony (a significant cause of postpartum hemorrhage), TRPV4-OXTR colocalization was markedly reduced vs. oxytocin-responsive uterine tissue — identifying TRPV4 deficiency as a potential mechanism of oxytocin resistance. For researchers: this discovery opens TRPV4 as a new research target for preterm labor (TRPV4 antagonists as potential tocolytics) and provides a mechanistic explanation for oxytocin treatment failure in postpartum hemorrhage. It also means that oxytocin dose-response assays for uterine contractility must account for TRPV4 expression levels in the cell model used.
The Cys1–Cys6 disulfide bond in oxytocin creates the cyclic hexapeptide ring that is essential for OXTR binding. The ring structure positions the Tyr2, Ile3, Gln4, Asn5 residues for receptor engagement in a specific three-dimensional conformation that cannot be achieved by the linear reduced form. If the disulfide bond is reduced (e.g., by DTT, TCEP, or reducing conditions) or scrambled (oxidized to non-native Cys1–Cys6 alternative pairing), the peptide loses OXTR affinity and biological activity. This is why oxytocin storage conditions matter: oxidizing agents, metal ions (Cu²+, Fe²+), UV light, and alkaline pH can all disrupt the disulfide bond. For COA quality verification: HPLC should show a single chromatographic peak; a broad peak, shoulder, or split peak may indicate disulfide-scrambled isomers or reduced form contamination. MS should confirm the correct molecular weight; the reduced form (+2 Da from addition of two H atoms) can be distinguished from the native disulfide form by high-resolution MS. Storing reconstituted oxytocin at slightly acidic pH (~4; achieved with 0.1% acetic acid) and avoiding freeze-thaw preserves disulfide bond integrity better than neutral-to-alkaline PBS alone.
Oxytocin and the HPA (hypothalamic-pituitary-adrenal) stress axis are functionally intertwined in a largely reciprocal manner. In the PVN (paraventricular nucleus of the hypothalamus), some neurons co-produce both CRH (corticotropin-releasing hormone, the primary driver of the stress response) and oxytocin. During stress, CRH-driven HPA activation elevates cortisol; simultaneously, PVN oxytocin neurons can dampen CRH release through local inhibitory connectivity, reducing downstream ACTH and cortisol responses. This oxytocinergic HPA inhibition is the mechanistic basis for the well-documented observation that affiliative social behaviors (which activate the oxytocin system) buffer cortisol stress responses — the physiological basis of social support’s stress-attenuating effect. The OXTR rs53576 GG variant is associated with lower cortisol reactivity to social stressors and greater social support-seeking behavior compared to AA carriers, linking individual genetic differences in OXTR to differences in stress physiology. For researchers: using oxytocin as a research tool in HPA axis studies requires careful attention to dose, route, and timing because chronic high-dose oxytocin can produce receptor downregulation and paradoxical effects in some contexts; acute lower-dose protocols typically better recapitulate endogenous HPA-dampening effects.
Oxytocin and vasopressin (AVP; arginine vasopressin) are structurally homologous nonapeptides that differ at only two amino acid positions (positions 3 and 8): oxytocin has Ile3 and Leu8; vasopressin has Phe3 and Arg8 (in most mammals). This similarity means oxytocin can bind vasopressin receptors (V1aR, V1bR, V2R) at high concentrations and vasopressin can bind OXTR at high concentrations, creating potential cross-reactivity in research models. For most research protocols using physiological or low pharmacological concentrations, the receptor selectivity is acceptable: oxytocin prefers OXTR > V1aR/V1bR/V2R; vasopressin prefers V1a/V1b/V2R > OXTR. However, for studies requiring strict receptor specificity (especially in brain regions expressing both OXTR and V1aR, such as the lateral septum and hippocampus), OXTR-selective agonists (e.g., [Thr4, Gly7]-oxytocin) or V1aR-selective antagonists should be used as controls to confirm that observed effects are OXTR-mediated. In uterine contraction research, standard research doses of oxytocin are highly selective for OXTR and do not significantly activate vasopressin receptors. In CNS research with intranasal or icv delivery, receptor cross-reactivity is a more relevant concern at higher doses.
Yes. YourPeptideBrand.com provides white-label dropship for oxytocin (Research Use Only). White-label storefronts include pre-built RUO-compliant product pages with OXTR/Gq/PLC-β/Ca²+ mechanism descriptions, TRPV4 colocalization 2024 discovery context, social behavior neuroscience and HPA axis research context, disulfide bond stability notes, and COA library links. Contact the YPB team for confirmed SKU, configuration, Premier and Core pricing, and use the profit calculator to model projected revenue.
Every oxytocin batch includes a lot-specific COA: HPLC purity (≥98%; single peak confirming intact disulfide-cyclic form; any shoulder or split peak indicating disulfide-scrambled isomers must be absent), MS confirmation at ~1,007 Da (cyclic disulfide form; reduced linear form would appear at ~1,009 Da — the +2 Da from the two additional H atoms is measurable by high-resolution MS), endotoxin (<1 EU/mg), TAMC, and TYMC. The single HPLC peak + correct MS at 1,007 Da (not 1,009 Da) is the critical structural quality confirmation for oxytocin: it simultaneously confirms the disulfide bond is intact (correct cyclic structure), C-terminal amidation is present, and no disulfide-scrambled or reduced forms contaminate the batch. All lots are traceable through the batch-specific COA library.
Oxytocin carries the highest public recognition of any neuropeptide in the catalog (“the love hormone” popular science narrative) — this name recognition drives catalog traffic from audiences who have heard of oxytocin through mainstream media and want to understand the actual research behind it. Position catalog content to bridge from the popular narrative (“social bonding hormone”) to rigorous mechanism (“OXTR/Gq/PLC-β/Ca²+ signaling in multiple tissues simultaneously”) to the breadth of research applications (reproductive biology, social neuroscience, HPA axis, bone, neuroimmune). The 2024 TRPV4-OXTR mechanistic discovery provides genuinely new research context to include in product descriptions. Key differentiating angles: (1) the most broadly expressed single-receptor neuropeptide in the catalog (OXTR in uterus, brain social circuits, HPA axis, bone, immune); (2) research-grade compound use context (Pitocin/Syntocinon for labor) establishes clinical credibility; (3) ASD research angle drives interest from neurodevelopmental disorder research community. For catalog pairs: oxytocin (OXTR/social/reproductive) + VIP (VPAC1/2/neuroimmune) + Selank (GABA/anxiety) = the complete neuropeptide behavioral biology trio.
Key Takeaways
Research Takeaways
- Nobel Prize neuropeptide (du Vigneaud 1953); >25,000 publications: Most extensively studied neuropeptide; simultaneously peripheral hormone and central neurotransmitter.
- OXTR Gq/G11 → PLC-β → IP3 → Ca²+ → MLCK: Primary contractility cascade; DAG → PKC → MAPK/ERK1/2; Gi/Go in some tissues; TRPV4 channel required for full uterine contractility response (2024).
- TRPV4-OXTR colocalization (2024, PMID: 41762213): New required mechanistic component for oxytocin-induced uterine contraction; TRPV4 antagonism abolishes Ca²+ influx; reduced in oxytocin-resistant atony research subjects.
- Social behavior: amygdala + NAc + PFC: Context-dependent effects; specify route (intranasal vs. icv vs. SC), sex, and behavioral context in all protocols.
- HPA axis: PVN oxytocin inhibits CRH → reduces cortisol; rs53576 OXTR variant links genetics to individual stress reactivity differences.
- Disulfide bond (Cys1–Cys6) required; sensitive to oxidation: Confirm single HPLC peak + 1,007 Da (not 1,009 Da reduced form); store in slightly acidic conditions.
- ~3–5 min plasma half-life (oxytocinase): Specify administration route; intranasal bypasses systemic degradation for CNS research.
Business Takeaways
- Highest public recognition neuropeptide in catalog (“love hormone”) — broad awareness drives organic catalog traffic across research and consumer-adjacent audiences.
- Broadest tissue application profile — reproductive biology (uterine), social neuroscience (amygdala/NAc), HPA axis, bone, neuroimmune; widest single-compound research audience.
- Oxytocin + VIP + Selank = complete neuropeptide behavioral biology trio: OXTR social/reproductive, VPAC1/2 neuroimmune/circadian, tuftsin/GABA anxiolytic.
- Contact YPB for confirmed SKU and pricing for oxytocin.
Ready to add oxytocin to your research catalog? Book a consultation with the YPB team.
[ypb_studies peptide=”oxytocin”]